跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OLUMIANT baricitinib 4 mg film-coated tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
OLUMIANT baricitinib 4 mg film-coated tablet blister pack
Approved
STANDARD
OLUMIANT baricitinib 4 mg film-coated tablet blister pack
Eli Lilly Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
de1824e5e50832ac
Company
Eli Lilly Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
de1824e5e50832ac
Product Name
OLUMIANT baricitinib 4 mg film-coated tablet blister pack
Artg Id
277917
Artg Name
OLUMIANT baricitinib 4 mg film-coated tablet blister pack
Sponsor
Eli Lilly Australia Pty Ltd
Company Detail Path
/organization/eli-lilly-australia-pty-ltd
Artg Date
2018-01-23
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/05019c1431dd5eadfe80eb881c2a20f5.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/af9ccf21fac2bb5237123ac742ecbde1.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
de1824e5e50832ac
Type
Standard
Back to TGA Approvals